Diamyd Medical AB (publ) reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported sales was SEK 0.113 million compared to SEK 0.231 million a year ago. Revenue was SEK 1.64 million compared to SEK 0.244 million a year ago. Net loss was SEK 24.97 million compared to SEK 8.98 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to SEK 0.1 a year ago.
For the six months, sales was SEK 0.324 million compared to SEK 0.358 million a year ago. Revenue was SEK 2.61 million compared to SEK 0.404 million a year ago. Net loss was SEK 57.93 million compared to SEK 46.48 million a year ago. Basic loss per share from continuing operations was SEK 0.8 compared to SEK 0.6 a year ago.